Keratoacanthoma within a superficial spreading malignant melanoma in situ.
PRAME Expression in Melanocytic Tumors.
Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ.
Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134.
Cutaneous melanoma in situ: a review.
Karponis D, Joshy J, Stratigos IA, Craig PJ, Mistry K, van Bodegraven B, Venables ZC, Levell NJ.
Clin Exp Dermatol. 2025 Feb 24;50(3):529-536. doi: 10.1093/ced/llae465.
Dermoscopic evaluation of superficial spreading melanoma.
Trindade FM, de Freitas MLP, Bittencourt FV.
An Bras Dermatol. 2021 Mar-Apr;96(2):139-147. doi: 10.1016/j.abd.2020.06.012. Epub 2021 Feb 1.
Risk of Mortality After a Diagnosis of Melanoma In Situ.
Patel VR, Roberson ML, Pignone MP, Adamson AS.
JAMA Dermatol. 2023 Jul 1;159(7):703-710. doi: 10.1001/jamadermatol.2023.1494.
Assessing the Efficacy of the Spectrum-Aided Vision Enhancer (SAVE) to Detect Acral Lentiginous Melanoma, Melanoma In Situ, Nodular Melanoma, and Superficial Spreading Melanoma.
Lin TL, Lu CT, Karmakar R, Nampalley K, Mukundan A, Hsiao YP, Hsieh SC, Wang HC.
Diagnostics (Basel). 2024 Aug 1;14(15):1672. doi: 10.3390/diagnostics14151672.
Preoperative bimodal imaging evaluation in finding histological correlations of in situ, superficial spreading and nodular melanoma.
Negrutiu M, Danescu S, Popa T, Rogojan L, Vesa SC, Baican A.
Front Med (Lausanne). 2024 Aug 9;11:1436078. doi: 10.3389/fmed.2024.1436078. eCollection 2024.
Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom.
Haroon S, Vithanage I, Rashid K, Aslam M, Elmahdy H, Zia S, Malik UA, Irfan M, Hashmi AA.
Cureus. 2023 Jun 2;15(6):e39874. doi: 10.7759/cureus.39874. eCollection 2023 Jun.
Malignant melanoma in situ.
Flotte TJ.
Hum Pathol. 1990 Dec;21(12):1199-201. doi: 10.1016/s0046-8177(06)80030-4.
[Nested melanoma].
Jegou MH, Huet P, Penchet I.
Ann Dermatol Venereol. 2017 Jan;144(1):60-64. doi: 10.1016/j.annder.2016.09.036. Epub 2016 Oct 19.
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin.
Sun C, Lim A, De'Ambrosis B, Yong-Gee S, Pool L, Muir J.
JAMA Dermatol. 2024 Aug 1;160(8):874-877. doi: 10.1001/jamadermatol.2024.1878.
